Literature DB >> 11953360

Protection against bacterial superantigen staphylococcal enterotoxin B by passive vaccination.

Ross D LeClaire1, Robert E Hunt, Sina Bavari.   

Abstract

We investigated the ability of two overlapping fragments of staphylococcal enterotoxin B (SEB), which encompass the whole toxin, to induce protection and also examined if passive transfer of chicken anti-SEB antibodies raised against the holotoxin could protect rhesus monkeys against aerosolized SEB. Although both fragments of SEB were highly immunogenic, the fragments failed to protect mice whether they were injected separately or injected together. Passive transfer of antibody generated in chickens (immunoglobulin Y [IgY]) against the whole toxin suppressed cytokine responses and was protective in mice. All rhesus monkeys treated with the IgY specific for SEB up to 4 h after challenge survived lethal SEB aerosol exposure. These findings suggest that large fragments of SEB may not be ideal for productive vaccination, but passive transfer of SEB-specific antibodies protects nonhuman primates against lethal aerosol challenge. Thus, antibodies raised in chickens against the holotoxin may have potential therapeutic value within a therapeutic window of opportunity after SEB encounter.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11953360      PMCID: PMC127924          DOI: 10.1128/IAI.70.5.2278-2281.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Inhibition of bacterial superantigens by peptides and antibodies.

Authors:  K Visvanathan; A Charles; J Bannan; P Pugach; K Kashfi; J B Zabriskie
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

2.  Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.

Authors:  G Arad; R Levy; D Hillman; R Kaempfer
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

3.  Superantigen vaccines: a comparative study of genetically attenuated receptor-binding mutants of staphylococcal enterotoxin A.

Authors:  S Bavari; B Dyas; R G Ulrich
Journal:  J Infect Dis       Date:  1996-08       Impact factor: 5.226

4.  T-cell antigen receptor binding sites for the microbial superantigen staphylococcal enterotoxin A.

Authors:  C H Pontzer; M J Irwin; N R Gascoigne; H M Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

5.  Mapping of multiple binding domains of the superantigen staphylococcal enterotoxin A for HLA.

Authors:  N D Griggs; C H Pontzer; M A Jarpe; H M Johnson
Journal:  J Immunol       Date:  1992-04-15       Impact factor: 5.422

6.  Development of engineered vaccines effective against structurally related bacterial superantigens.

Authors:  R G Ulrich; M A Olson; S Bavari
Journal:  Vaccine       Date:  1998-11       Impact factor: 3.641

Review 7.  Bacterial superantigens in human disease: structure, function and diversity.

Authors:  R G Ulrich; S Bavari; M A Olson
Journal:  Trends Microbiol       Date:  1995-12       Impact factor: 17.079

8.  The staphylococcal enterotoxins and their relatives.

Authors:  P Marrack; J Kappler
Journal:  Science       Date:  1990-06-01       Impact factor: 47.728

9.  Human antibodies to bacterial superantigens and their ability to inhibit T-cell activation and lethality.

Authors:  R D LeClaire; S Bavari
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

Review 10.  MHC class II antigen processing: biology of invariant chain.

Authors:  A J Sant; J Miller
Journal:  Curr Opin Immunol       Date:  1994-02       Impact factor: 7.486

View more
  36 in total

Review 1.  Novel targeted immunotherapy approaches for staphylococcal infection.

Authors:  Michael Otto
Journal:  Expert Opin Biol Ther       Date:  2010-07       Impact factor: 4.388

2.  A mutant of staphylococcal enterotoxin C devoid of bacterial superantigenic activity elicits a Th2 immune response for protection against Staphylococcus aureus infection.

Authors:  Dong-Liang Hu; Jing-Chun Cui; Katsuhiko Omoe; Hiroshi Sashinami; Yuichi Yokomizo; Kunihiro Shinagawa; Akio Nakane
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 3.  The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections.

Authors:  Gordon Y C Cheung; Michael Otto
Journal:  Expert Opin Ther Targets       Date:  2012-04-25       Impact factor: 6.902

4.  Neutralization of staphylococcal enterotoxin B by an aptamer antagonist.

Authors:  Kaiyu Wang; Longjie Gan; Li Jiang; Xianhui Zhang; Xiangyue Yang; Min Chen; Xiaopeng Lan
Journal:  Antimicrob Agents Chemother       Date:  2015-01-26       Impact factor: 5.191

5.  Antibody responses in patients with invasive Staphylococcus aureus infections.

Authors:  G Jacobsson; P Colque-Navarro; E Gustafsson; R Andersson; R Möllby
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-04-10       Impact factor: 3.267

6.  Determining the immunological characteristics of a novel human monoclonal antibody developed against staphylococcal enterotoxin B.

Authors:  Yuanyuan Liu; Zhen Song; Shuang Ge; Jinyong Zhang; Limin Xu; Feng Yang; Dongshui Lu; Ping Luo; Jiang Gu; Quanming Zou; Hao Zeng
Journal:  Hum Vaccin Immunother       Date:  2020-04-10       Impact factor: 3.452

7.  Generation, characterization, and epitope mapping of neutralizing and protective monoclonal antibodies against staphylococcal enterotoxin B-induced lethal shock.

Authors:  Avanish K Varshney; Xiaobo Wang; Emily Cook; Kaushik Dutta; Matthew D Scharff; Michael J Goger; Bettina C Fries
Journal:  J Biol Chem       Date:  2011-01-13       Impact factor: 5.157

8.  Bacterial Toxins-Staphylococcal Enterotoxin B.

Authors:  Bettina C Fries; Avanish K Varshney
Journal:  Microbiol Spectr       Date:  2013-12

9.  Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients.

Authors:  Agnieszka Dryla; Sonja Prustomersky; Dieter Gelbmann; Markus Hanner; Edith Bettinger; Béla Kocsis; Tamás Kustos; Tamás Henics; Andreas Meinke; Eszter Nagy
Journal:  Clin Diagn Lab Immunol       Date:  2005-03

10.  Inhibition of toxic shock by human monoclonal antibodies against staphylococcal enterotoxin B.

Authors:  Eileen A Larkin; Bradley G Stiles; Robert G Ulrich
Journal:  PLoS One       Date:  2010-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.